Cargando…
The ‘Swallow Tail’ Appearance of the Healthy Nigrosome – A New Accurate Test of Parkinson's Disease: A Case-Control and Retrospective Cross-Sectional MRI Study at 3T
There is no well-established in vivo marker of nigral degeneration in Parkinson's disease (PD). An ideal imaging marker would directly mirror the loss of substantia nigra dopaminergic neurones, which is most prominent in sub-regions called nigrosomes. High-resolution, iron-sensitive, magnetic r...
Autores principales: | Schwarz, Stefan T., Afzal, Mohammed, Morgan, Paul S., Bajaj, Nin, Gowland, Penny A., Auer, Dorothee P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3977922/ https://www.ncbi.nlm.nih.gov/pubmed/24710392 http://dx.doi.org/10.1371/journal.pone.0093814 |
Ejemplares similares
-
Parkinson's disease related signal change in the nigrosomes 1–5 and the substantia nigra using T2* weighted 7T MRI
por: Schwarz, Stefan Theodor, et al.
Publicado: (2018) -
Protocol of a single group prospective observational study on the diagnostic value of 3T susceptibility weighted MRI of nigrosome-1 in patients with parkinsonian symptoms: the N3iPD study (nigrosomal iron imaging in Parkinson’s disease)
por: Schwarz, Stefan T, et al.
Publicado: (2017) -
Nigrosome and Neuromelanin Imaging as Tools to Differentiate Parkinson's Disease and Parkinsonism
por: Biswas, Deblina, et al.
Publicado: (2022) -
Diffusion tensor imaging of nigral degeneration in Parkinson's disease: A region-of-interest and voxel-based study at 3 T and systematic review with meta-analysis()
por: Schwarz, Stefan T., et al.
Publicado: (2013) -
Modified Iron Deposition in Nigrosomes by Pharmacotherapy for the Management of Parkinson’s Disease
por: Wang, Mengdi, et al.
Publicado: (2022)